Assessment of Safety and Efficacy of Insulin NPH [insulin suspension isophane] Compared to a New Insulin Formulation on Glycaemic Control in Subjects With Type 2 Diabetes.
Phase of Trial: Phase II
Latest Information Update: 08 May 2015
At a glance
- Drugs EX 1000 (Primary) ; Insulin; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 14 Oct 2010 Actual end date changed from Feb 2009 to Mar 2009 as reported by ClinicalTrials.gov.
- 14 Oct 2010 Actual initiation date changed from Apr 2008 to Feb 2008 as reported by ClinicalTrials.gov.